Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Frederic Quitkin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Devices

Placebos

Procedures

Phenomena

Recurrence

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Stewart Jonathan W; McGrath Patrick J; Quitkin Frederic M; Klein Donald F
DSM-IV depression with atypical features: is it valid?
Stewart Jonathan W; McGrath Patrick J; Deliyannides Rodeborah A; Quitkin Frederic M
Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?
Bruder Gerard E; Sedoruk James P; Stewart Jonathan W; McGrath Patrick J; Quitkin Frederic M; Tenke Craig E
Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Frederic Quitkin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Stewart Jonathan W; McGrath Patrick J; Quitkin Frederic M; Klein Donald F
DSM-IV depression with atypical features: is it valid?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(13):2625-32.
2009: Stewart Jonathan W; McGrath Patrick J; Deliyannides Rodeborah A; Quitkin Frederic M
Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?
Journal of psychiatric practice 2009;15(5):337-45.
2008: Bruder Gerard E; Sedoruk James P; Stewart Jonathan W; McGrath Patrick J; Quitkin Frederic M; Tenke Craig E
Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.
Biological psychiatry 2008;63(12):1171-7.
2007: Cusin Cristina; Fava Maurizio; Amsterdam Jay D; Quitkin Frederic M; Reimherr Frederick W; Beasley Charles M; Rosenbaum Jerrold F; Perlis Roy H
Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications.
The Journal of clinical psychiatry 2007;68(1):52-7.
2007: Perlis Roy H; Beasley Charles M; Wines James D; Tamura Roy N; Cusin Cristina; Shear Deborah; Amsterdam Jay; Quitkin Frederick; Strong Robert E; Rosenbaum Jerrold F; Fava Maurizio
Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes.
Psychotherapy and psychosomatics 2007;76(1):40-6.
2006: McGrath Patrick J; Stewart Jonathan W; Quitkin Frederic M; Chen Ying; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio; Cheng Jianfeng; Petkova Eva
Predictors of relapse in a prospective study of fluoxetine treatment of major depression.
The American journal of psychiatry 2006;163(9):1542-8.
2006: Trivedi Madhukar H; Fava Maurizio; Wisniewski Stephen R; Thase Michael E; Quitkin Frederick; Warden Diane; Ritz Louise; Nierenberg Andrew A; Lebowitz Barry D; Biggs Melanie M; Luther James F; Shores-Wilson Kathy; Rush A John;
Medication augmentation after the failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1243-52.
2006: Taylor Bonnie P; Bruder Gerard E; Stewart Jonathan W; McGrath Patrick J; Halperin Jeffrey; Ehrlichman Howard; Quitkin Frederic M
Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients.
The American journal of psychiatry 2006;163(1):73-8.
2005: Quitkin Frederic M; McGrath Patrick J; Stewart Jonathan W; Klein Donald F; Ross Donald C
Accurate meta-analytical assessment of "true antidepressant effects" needed.
The Journal of clinical psychiatry 2005;66(9):1192; author reply 1192-3.
2005: Quitkin Frederic M; McGrath Patrick J; Stewart Jonathan W; Deliyannides Deborah; Taylor Bonnie P; Davies Carrie A; Klein Donald F
Remission rates with 3 consecutive antidepressant trials: effectiveness for depressed outpatients.
The Journal of clinical psychiatry 2005;66(6):670-6.
2005: Stewart Jonathan W; Quitkin Frederic M; McGrath Patrick J; Klein Donald F
Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
Journal of affective disorders 2005;86(2-3):161-7.
2005: Taylor Bonnie P; Quitkin Frederic M; McGrath Patrick J; Stewart Jonathan W
Do antihypertensives make tranylcypromine safer? Three case reports.
The Journal of clinical psychiatry 2005;66(5):657-8.
2005: Davis Lori L; Rush John A; Wisniewski Stephen R; Rice Kayla; Cassano Paolo; Jewell Michele E; Biggs Melanie M; Shores-Wilson Kathy; Balasubramani G K; Husain Mustafa M; Quitkin Frederic M; McGrath Patrick J
Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.
Comprehensive psychiatry 2005;46(2):81-9.
2004: Bruder Gerard E; Stewart Jonathan W; McGrath Patrick J; Deliyannides Deborah; Quitkin Frederic M
Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(9):1752-61.
2004: Wisniewski Stephen R; Stegman Diane; Trivedi Madhukar; Husain Mustafa M; Eng Heather; Shores-Wilson Kathy; Luther James; Biggs Melanie M; Burroughs Diane; Ritz A Louise; Fava Maurizio; Quitkin Frederic; Rush A John;
Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D).
Journal of psychiatric research 2004;38(3):241-8.
2004: Nierenberg Andrew A; Quitkin Frederic M; Kremer Charlotte; Keller Martin B; Thase Michael E
Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(5):1012-8.
2004: Rush A John; Fava Maurizio; Wisniewski Stephen R; Lavori Philip W; Trivedi Madhukar H; Sackeim Harold A; Thase Michael E; Nierenberg Andrew A; Quitkin Frederic M; Kashner T Michael; Kupfer David J; Rosenbaum Jerrold F; Alpert Jonathan; Stewart Jonathan W; McGrath Patrick J; Biggs Melanie M; Shores-Wilson Kathy; Lebowitz Barry D; Ritz Louise; Niederehe George;
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
Controlled clinical trials 2004;25(1):119-42.
2004: Bruder Gerard E; Schneier Franklin R; Stewart Jonathan W; McGrath Patrick J; Quitkin Frederic
Left hemisphere dysfunction during verbal dichotic listening tests in patients who have social phobia with or without comorbid depressive disorder.
The American journal of psychiatry 2004;161(1):72-8.
2003: Donovan Stephen J; Nunes Edward V; Stewart Jonathan W; Ross Don; Quitkin Frederic M; Jensen Peter S; Klein Donald F
"Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder?
The Journal of clinical psychiatry 2003;64(6):698-701.
2003: Fava Maurizio; Rush A John; Trivedi Madhukar H; Nierenberg Andrew A; Thase Michael E; Sackeim Harold A; Quitkin Frederic M; Wisniewski Steven; Lavori Philip W; Rosenbaum Jerrold F; Kupfer David J
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.
The Psychiatric clinics of North America 2003;26(2):457-94, x.
2003: Stewart Jonathan W; Bruder Gerard E; McGrath Patrick J; Quitkin Frederic M
Do age of onset and course of illness define biologically distinct groups within atypical depression?
Journal of abnormal psychology 2003;112(2):253-62.
2003: Quitkin Frederic M; McGrath Patrick J; Stewart Jonathan W; Klein Donald F
A reappraisal of atypical depression.
The American journal of psychiatry 2003;160(4):798-800; author reply 800-1.
2003: Quitkin Frederic M; Petkova Eva; McGrath Patrick J; Taylor Bonnie; Beasley Charles; Stewart Jonathan; Amsterdam Jay; Fava Maurizio; Rosenbaum Jerrold; Reimherr Frederick; Fawcett Jan; Chen Ying; Klein Donald
When should a trial of fluoxetine for major depression be declared failed?
The American journal of psychiatry 2003;160(4):734-40.
2003: Fava Maurizio; Papakostas George I; Petersen Timothy; Mahal Yasmin; Quitkin Frederick; Stewart Jonathan; McGrath Patrick
Switching to bupropion in fluoxetine-resistant major depressive disorder.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2003;15(1):17-22.
2003: Quitkin Frederic M; Garakani Amir; Kelly Katie E
Electrolyte-balanced sports drink for polydipsia-hyponatremia in schizophrenia.
The American journal of psychiatry 2003;160(2):385-6.
2002: Quitkin Frederic M; Stewart Jonathan W; McGrath Patrick J; Taylor Bonnie P; Tisminetzky Mayra S; Petkova Eva; Chen Ying; Ma Guoguang; Klein Donald F
Are there differences between women's and men's antidepressant responses?
The American journal of psychiatry 2002;159(11):1848-54.
2002: Agosti V; Quitkin F M; Stewart J W; McGrath P J
Somatization as a predictor of medication discontinuation due to adverse events.
International clinical psychopharmacology 2002;17(6):311-4.
2002: Montgomery Stuart A; Bech Per; Blier Pierre; Möller Hans-Jürgen; Nierenberg Andrew A; Pinder Roger M; Quitkin Frederic M; Reimitz Paul-Egbert; Rosenbaum Jerrold F; Rush A John; Stassen H H; Thase Michael E
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
The Journal of clinical psychiatry 2002;63(8):694-9.
2002: Ross Donald C; Quitkin Frederick M; Klein Donald F
A typological model for estimation of drug and placebo effects in depression.
Journal of clinical psychopharmacology 2002;22(4):414-8.
2002: Bruder Gerard E; Stewart Jonathan W; McGrath Patrick J; Ma Guoguang Julie; Wexler Bruce E; Quitkin Frederic M
Atypical depression: enhanced right hemispheric dominance for perceiving emotional chimeric faces.
Journal of abnormal psychology 2002;111(3):446-54.
2002: Bruder Gerard E; Kayser Jürgen; Tenke Craig E; Leite Paul; Schneier Franklin R; Stewart Jonathan W; Quitkin Frederic M
Cognitive ERPs in depressive and anxiety disorders during tonal and phonetic oddball tasks.
Clinical EEG (electroencephalography) 2002;33(3):119-24.
2002: Brunswick David J; Amsterdam Jay D; Fawcett Jan; Quitkin Frederic M; Reimherr Frederick W; Rosenbaum Jerrold F; Beasley Charles M
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment.
Journal of affective disorders 2002;68(2-3):243-9.
2002: Stewart Jonathan W; McGrath Patrick J; Quitkin Frederic M
Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(2):237-45.
2001: Brunswick D J; Amsterdam J D; Fawcett J; Quitkin F M; Reimherr F W; Rosenbaum J F; Beasley C M
Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapy.
Journal of clinical psychopharmacology 2001;21(6):616-8.
2001: Lavori P W; Rush A J; Wisniewski S R; Alpert J; Fava M; Kupfer D J; Nierenberg A; Quitkin F M; Sackeim H A; Thase M E; Trivedi M
Strengthening clinical effectiveness trials: equipoise-stratified randomization.
Biological psychiatry 2001;50(10):792-801.
2001: Quitkin F M; Taylor B P; Kremer C
Does mirtazapine have a more rapid onset than SSRIs?
The Journal of clinical psychiatry 2001;62(5):358-61.
2001: Bruder G E; Stewart J W; Tenke C E; McGrath P J; Leite P; Bhattacharya N; Quitkin F M
Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant.
Biological psychiatry 2001;49(5):416-25.
2000: McGrath P J; Nunes E V; Quitkin F M
Current concepts in the treatment of depression in alcohol-dependent patients.
The Psychiatric clinics of North America 2000;23(4):695-711, V.
2000: McGrath P J; Stewart J W; Petkova E; Quitkin F M; Amsterdam J D; Fawcett J; Reimherr F W; Rosenbaum J F; Beasley C M
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression.
The Journal of clinical psychiatry 2000;61(7):518-24.
2000: Petkova E; Quitkin F M; McGrath P J; Stewart J W; Klein D F
A method to quantify rater bias in antidepressant trials.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(6):559-65.
2000: Kayser J; Bruder G E; Tenke C E; Stewart J E; Quitkin F M
Event-related potentials (ERPs) to hemifield presentations of emotional stimuli: differences between depressed patients and healthy adults in P3 amplitude and asymmetry.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2000;36(3):211-36.
2000: Donovan S J; Stewart J W; Nunes E V; Quitkin F M; Parides M; Daniel W; Susser E; Klein D F
Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.
The American journal of psychiatry 2000;157(5):818-20.
2000: Quitkin F M; Klein D F
What conditions are necessary to assess antidepressant efficacy?
Archives of general psychiatry 2000;57(4):323-4.
2000: McGrath P J; Stewart J W; Janal M N; Petkova E; Quitkin F M; Klein D F
A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.
The American journal of psychiatry 2000;157(3):344-50.
2000: Quitkin F M; Rabkin J G; Gerald J; Davis J M; Klein D F
Validity of clinical trials of antidepressants.
The American journal of psychiatry 2000;157(3):327-37.
1999: Stewart J W; Quitkin F M; McGrath P J; Bruder G E
Do tricyclic responders have different brain laterality?
Journal of abnormal psychology 1999;108(4):707-10.
1999: Amsterdam J; Garcia-España F; Fawcett J; Quitkin F; Reimherr F; Rosenbaum J; Beasley C
Fluoxetine efficacy in menopausal women with and without estrogen replacement.
Journal of affective disorders 1999;55(1):11-7.
1999: Michelson D; Amsterdam J D; Quitkin F M; Reimherr F W; Rosenbaum J F; Zajecka J; Sundell K L; Kim Y; Beasley C M
Changes in weight during a 1-year trial of fluoxetine.
The American journal of psychiatry 1999;156(8):1170-6.
1999: Zajecka J; Amsterdam J D; Quitkin F M; Reimherr F W; Rosenbaum J F; Tamura R N; Sundell K L; Michelson D; Beasley C M
Changes in adverse events reported by patients during 6 months of fluoxetine therapy.
The Journal of clinical psychiatry 1999;60(6):389-94.
1999: Quitkin F M
Placebos, drug effects, and study design: a clinician's guide.
The American journal of psychiatry 1999;156(6):829-36.
1999: Bruder G E; Wexler B E; Stewart J W; Price L H; Quitkin F M
Perceptual asymmetry differences between major depression with or without a comorbid anxiety disorder: a dichotic listening study.
Journal of abnormal psychology 1999;108(2):233-9.
1999: Amsterdam J D; Garcia-Espana F; Fawcett J; Quitkin F M; Reimherr F W; Rosenbaum J F; Beasley C
Blood pressure changes during short-term fluoxetine treatment.
Journal of clinical psychopharmacology 1999;19(1):9-14.
1999: Bruder G E; Tenke C E; Stewart J W; McGrath P J; Quitkin F M
Predictors of therapeutic response to treatments for depression: a review of electrophysiologic and dichotic listening studies.
CNS spectrums 1999;4(8):30-6.
1998: Amsterdam J D; Garcia-España F; Fawcett J; Quitkin F M; Reimherr F W; Rosenbaum J F; Schweizer E; Beasley C
Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.
Journal of clinical psychopharmacology 1998;18(6):435-40.
1998: Quitkin F M; McGrath P J; Stewart J W; Ocepek-Welikson K; Taylor B P; Nunes E; Delivannides D; Agosti V; Donovan S J; Ross D; Petkova E; Klein D F
Placebo run-in period in studies of depressive disorders. Clinical, heuristic and research implications.
The British journal of psychiatry : the journal of mental science 1998;173():242-8.
1998: Reimherr F W; Amsterdam J D; Quitkin F M; Rosenbaum J F; Fava M; Zajecka J; Beasley C M; Michelson D; Roback P; Sundell K
Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.
The American journal of psychiatry 1998;155(9):1247-53.
1998: Zajecka J; Fawcett J; Amsterdam J; Quitkin F; Reimherr F; Rosenbaum J; Michelson D; Beasley C
Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study.
Journal of clinical psychopharmacology 1998;18(3):193-7.
1998: Stewart J W; Quitkin F M; McGrath P J; Amsterdam J; Fava M; Fawcett J; Reimherr F; Rosenbaum J; Beasley C; Roback P
Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.
Archives of general psychiatry 1998;55(4):334-43.
1998: Nunes E V; Quitkin F M; Donovan S J; Deliyannides D; Ocepek-Welikson K; Koenig T; Brady R; McGrath P J; Woody G
Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.
Archives of general psychiatry 1998;55(2):153-60.
1998: Bruder G E; Tenke C E; Towey J P; Leite P; Fong R; Stewart J E; McGrath P J; Quitkin F M
Brain ERPs of depressed patients to complex tones in an oddball task: relation of reduced P3 asymmetry to physical anhedonia.
Psychophysiology 1998;35(1):54-63.
1997: Amsterdam J D; Fawcett J; Quitkin F M; Reimherr F W; Rosenbaum J F; Michelson D; Hornig-Rohan M; Beasley C M
Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.
The American journal of psychiatry 1997;154(7):963-9.
1997: Bruder G E; Fong R; Tenke C E; Leite P; Towey J P; Stewart J E; McGrath P J; Quitkin F M
Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic study.
Biological psychiatry 1997;41(9):939-48.
1997: Bruder G E; Stewart J W; Mercier M A; Agosti V; Leite P; Donovan S; Quitkin F M
Outcome of cognitive-behavioral therapy for depression: relation to hemispheric dominance for verbal processing.
Journal of abnormal psychology 1997;106(1):138-44.
1997: Donovan S J; Susser E S; Nunes E V; Stewart J W; Quitkin F M; Klein D F
Divalproex treatment of disruptive adolescents: a report of 10 cases.
The Journal of clinical psychiatry 1997;58(1):12-5.
1996: Quitkin F M; McGrath P J; Stewart J W; Taylor B P; Klein D F
Can the effects of antidepressants be observed in the first two weeks of treatment?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(4):390-4.
1996: Quitkin F M; McGrath P J; Stewart J W; Ocepek-Welikson K; Taylor B P; Nunes E; Deliyannides D; Agosti V; Donovan S J; Petkova E; Klein D F
Chronological milestones to guide drug change. When should clinicians switch antidepressants?
Archives of general psychiatry 1996;53(9):785-92.
1996: Bruder G E; Otto M W; McGrath P J; Stewart J W; Fava M; Rosenbaum J F; Quitkin F M
Dichotic listening before and after fluoxetine treatment for major depression: relations of laterality to therapeutic response.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(2):171-9.
1996: McGrath P J; Nunes E V; Stewart J W; Goldman D; Agosti V; Ocepek-Welikson K; Quitkin F M
Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial.
Archives of general psychiatry 1996;53(3):232-40.
1995: Nunes E V; McGrath P J; Quitkin F M; Ocepek-Welikson K; Stewart J W; Koenig T; Wager S; Klein D F
Imipramine treatment of cocaine abuse: possible boundaries of efficacy.
Drug and alcohol dependence 1995;39(3):185-95.
1995: Bruder G E; Tenke C E; Stewart J W; Towey J P; Leite P; Voglmaier M; Quitkin F M
Brain event-related potentials to complex tones in depressed patients: relations to perceptual asymmetry and clinical features.
Psychophysiology 1995;32(4):373-81.
1995: Nunes E V; McGrath P J; Quitkin F M
Treating anxiety in patients with alcoholism.
The Journal of clinical psychiatry 1995;56 Suppl 2():3-9.
1994: McGrath P J; Stewart J W; Quitkin F M; Wager S; Jenkins S W; Archibald D G; Stringfellow J C; Robinson D S
Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement.
Journal of clinical psychopharmacology 1994;14(5):347-52.
1994: McGrath P J; Stewart J W; Nunes E N; Quitkin F M
Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
The Journal of clinical psychiatry 1994;55(8):336-9.
1994: Nunes E V; Donovan S J; Brady R; Quitkin F M
Evaluation and treatment of mood and anxiety disorders in opioid-dependent patients.
Journal of psychoactive drugs 1994;26(2):147-53.
1994: Donovan S J; Quitkin F M; Stewart J W; Ocepek-Welikson K; Harrison W; McGrath P J; Nunes E V; Wager S; Tricamo E
Duration of antidepressant trials: clinical and research implications.
Journal of clinical psychopharmacology 1994;14(1):64-6.
1994: Rothschild R; Quitkin H M; Quitkin F M; Stewart J W; Ocepek-Welikson K; McGrath P J; Tricamo E
A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.
The International journal of eating disorders 1994;15(1):1-9.
1994: Nunes E; Quitkin F; Brady R; Post-Koenig T
Antidepressant treatment in methadone maintenance patients.
Journal of addictive diseases 1994;13(3):13-24.
1993: Stewart J W; McGrath P J; Quitkin F M; Rabkin J G; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
Chronic depression: response to placebo, imipramine, and phenelzine.
Journal of clinical psychopharmacology 1993;13(6):391-6.
1993: Stewart J W; McGrath P J; Rabkin J G; Quitkin F M
Atypical depression. A valid clinical entity?
The Psychiatric clinics of North America 1993;16(3):479-95.
1993: Quitkin F M; Stewart J W; McGrath P J; Tricamo E; Rabkin J G; Ocepek-Welikson K; Nunes E; Harrison W; Klein D F
Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
The British journal of psychiatry. Supplement 1993;(21):30-4.
1993: Quitkin F M
[Impact of personality factors in depression]
L'Encéphale 1993;19 Spec No 3():491-2.
1993: Nunes E V; McGrath P J; Quitkin F M; Stewart J P; Harrison W; Tricamo E; Ocepek-Welikson K
Imipramine treatment of alcoholism with comorbid depression.
The American journal of psychiatry 1993;150(6):963-5.
1993: McGrath P J; Stewart J W; Tricamo E; Nunes E N; Quitkin F M
Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents.
Journal of clinical psychopharmacology 1993;13(3):224-5.
1993: Agosti V; Stewart J W; Quitkin F M; Ocepek-Welikson K
How symptomatic do depressed patients remain after benefiting from medication treatment?
Comprehensive psychiatry 1993;34(3):182-6.
1993: Quitkin F M; Stewart J W; McGrath P J; Nunes E; Ocepek-Welikson K; Tricamo E; Rabkin J G; Klein D F
Further evidence that a placebo response to antidepressants can be identified.
The American journal of psychiatry 1993;150(4):566-70.
1993: Quitkin F M; Stewart J W; McGrath P J; Nunes E; Ocepek-Welikson K; Tricamo E; Rabkin J G; Ross D; Klein D F
Loss of drug effects during continuation therapy.
The American journal of psychiatry 1993;150(4):562-5.
1993: Stewart J W; Mercier M A; Agosti V; Guardino M; Quitkin F M
Imipramine is effective after unsuccessful cognitive therapy: sequential use of cognitive therapy and imipramine in depressed outpatients.
Journal of clinical psychopharmacology 1993;13(2):114-9.
1993: McGrath P J; Stewart J W; Nunes E V; Ocepek-Welikson K; Rabkin J G; Quitkin F M; Klein D F
A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.
The American journal of psychiatry 1993;150(1):118-23.
1993: Goehl L; Nunes E; Quitkin F; Hilton I
Social networks and methadone treatment outcome: the costs and benefits of social ties.
The American journal of drug and alcohol abuse 1993;19(3):251-62.
1992: Bruder G E; Stewart J W; Towey J P; Friedman D; Tenke C E; Voglmaier M M; Leite P; Cohen P; Quitkin F M
Abnormal cerebral laterality in bipolar depression: convergence of behavioral and brain event-related potential findings.
Biological psychiatry 1992;32(1):33-47.
1992: McGrath P J; Stewart J W; Harrison W M; Ocepek-Welikson K; Rabkin J G; Nunes E N; Wager S G; Tricamo E; Quitkin F M; Klein D F
Predictive value of symptoms of atypical depression for differential drug treatment outcome.
Journal of clinical psychopharmacology 1992;12(3):197-202.
1992: Mercier M A; Stewart J W; Quitkin F M
A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression.
The Journal of clinical psychiatry 1992;53(5):166-70.
1992: Stewart J W; McGrath P J; Quitkin F M
Can mildly depressed outpatients with atypical depression benefit from antidepressants?
The American journal of psychiatry 1992;149(5):615-9.
1992: Stewart J W; Quitkin F M; Klein D F
The pharmacotherapy of minor depression.
American journal of psychotherapy 1992;46(1):23-36.
1992: Rothschild R; Quitkin F M
Review of the use of pattern analysis to differentiate true drug and placebo responses.
Psychotherapy and psychosomatics 1992;58(3-4):170-7.
1991: Agosti V; Stewart J W; Quitkin F M
Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants.
Journal of affective disorders 1991;23(1):35-41.
1991: Bruder G E; Towey J P; Stewart J W; Friedman D; Tenke C; Quitkin F M
Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P3 latency.
Biological psychiatry 1991;30(3):233-46.
1991: Nunes E V; Quitkin F M; Brady R; Stewart J W
Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use.
The American journal of psychiatry 1991;148(5):667-9.
1991: Quitkin F M; Harrison W; Stewart J W; McGrath P J; Tricamo E; Ocepek-Welikson K; Rabkin J G; Wager S G; Nunes E; Klein D F
Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design.
Archives of general psychiatry 1991;48(4):319-23.
1991: Agosti V; Nunes E; Stewart J W; Quitkin F M
Patient factors related to early attrition from an outpatient cocaine research clinic: a preliminary report.
The International journal of the addictions 1991;26(3):327-34.
1991: Quitkin F M; McGrath P J; Rabkin J G; Stewart J W; Harrison W; Ross D C; Tricamo E; Fleiss J; Markowitz J; Klein D F
Different types of placebo response in patients receiving antidepressants.
The American journal of psychiatry 1991;148(2):197-203.
1991: Quitkin F M; Rabkin J G; Stewart J W; McGrath P J; Harrison W; Ross D C; Tricamo E; Fleiss J; Markowitz J; Klein D F
Heterogeneity of clinical response during placebo treatment.
The American journal of psychiatry 1991;148(2):193-6.
1990: Rabkin J G; McGrath P J; Quitkin F M; Tricamo E; Stewart J W; Klein D F
Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression.
The American journal of psychiatry 1990;147(12):1622-6.
1990: Quitkin F M; McGrath P J; Stewart J W; Harrison W; Tricamo E; Wager S G; Ocepek-Welikson K; Nunes E; Rabkin J G; Klein D F
Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
Archives of general psychiatry 1990;47(10):935-41.
1990: Hollander E; Nunes E; DeCaria C M; Quitkin F M; Cooper T; Wager S; Klein D F
Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
Psychiatry research 1990;33(2):161-9.
1990: Stewart J W; Quitkin F M; Terman M; Terman J S
Is seasonal affective disorder a variant of atypical depression? Differential response to light therapy.
Psychiatry research 1990;33(2):121-8.
1990: Nunes E V; McGrath P J; Wager S; Quitkin F M
Lithium treatment for cocaine abusers with bipolar spectrum disorders.
The American journal of psychiatry 1990;147(5):655-7.
1990: Bruder G E; Stewart J W; Voglmaier M M; Harrison W M; McGrath P; Tricamo E; Quitkin F M
Cerebral laterality and depression: relations of perceptual asymmetry to outcome of treatment with tricyclic antidepressants.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1990;3(1):1-10.
1990: Wager S; Robinson D; Goetz R; Nunes E; Gully R; Quitkin F
Cholinergic REM sleep induction in atypical depression.
Biological psychiatry 1990;27(4):441-6.
1990: Terman J S; Terman M; Schlager D; Rafferty B; Rosofsky M; Link M J; Gallin P F; Quitkin F M
Efficacy of brief, intense light exposure for treatment of winter depression.
Psychopharmacology bulletin 1990;26(1):3-11.
1989: Stewart J W; McGrath P J; Quitkin F M; Harrison W; Markowitz J; Wager S; Leibowitz M R
Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.
Archives of general psychiatry 1989;46(12):1080-7.
1989: Quitkin F M; McGrath P J; Stewart J W; Harrison W; Wager S G; Nunes E; Rabkin J G; Tricamo E; Markowitz J; Klein D F
Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
Archives of general psychiatry 1989;46(9):787-93.
1989: Bruder G E; Quitkin F M; Stewart J W; Martin C; Voglmaier M M; Harrison W M
Cerebral laterality and depression: differences in perceptual asymmetry among diagnostic subtypes.
Journal of abnormal psychology 1989;98(2):177-86.
1989: Nunes E V; Quitkin F M; Klein D F
Psychiatric diagnosis in cocaine abuse.
Psychiatry research 1989;28(1):105-14.
1989: Terman M; Terman J S; Quitkin F M; McGrath P J; Stewart J W; Rafferty B
Light therapy for seasonal affective disorder. A review of efficacy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1989;2(1):1-22.
1989: Harrison W M; McGrath P J; Stewart J W; Quitkin F
MAOIs and hypertensive crises: the role of OTC drugs.
The Journal of clinical psychiatry 1989;50(2):64-5.
1989: Parsons B; Quitkin F M; McGrath P J; Stewart J W; Tricamo E; Ocepek-Welikson K; Harrison W; Rabkin J G; Wager S G; Nunes E
Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.
Psychopharmacology bulletin 1989;25(4):524-34.
1989: McGrath P J; Stewart J W; Harrison W; Wager S; Nunes E N; Quitkin F M
A placebo-controlled trial of L-deprenyl in atypical depression.
Psychopharmacology bulletin 1989;25(1):63-7.
1988: McGrath P J; Cooper T B; Quitkin F M; Klein D F
Effects of imipramine and phenelzine on plasma PEA levels.
Psychiatry research 1988;26(2):239.
1988: Nunes E; Quitkin F; Berman C
Panic disorder and depression in female alcoholics.
The Journal of clinical psychiatry 1988;49(11):441-3.
1988: Stewart J W; Quitkin F M; McGrath P J; Rabkin J G; Markowitz J S; Tricamo E; Klein D F
Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment.
Psychiatry research 1988;25(2):213-22.
1988: McGrath P J; Stewart J W; Liebowitz M R; Markowitz J M; Quitkin F M; Klein D F; Gorman J M
Lactate provocation of panic attacks in depressed outpatients.
Psychiatry research 1988;25(1):41-7.
1988: Agosti V; Stewart J W; Quitkin F M; Rabkin J G; McGrath P J; Markowitz J
Factors associated with premature medication discontinuation among responders to an MAOI or a tricyclic antidepressant.
The Journal of clinical psychiatry 1988;49(5):196-8.
1988: Quitkin F M; Stewart J W; McGrath P J; Liebowitz M R; Harrison W M; Tricamo E; Klein D F; Rabkin J G; Markowitz J S; Wager S G
Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
The American journal of psychiatry 1988;145(3):306-11.
1988: Liebowitz M R; Quitkin F M; Stewart J W; McGrath P J; Harrison W M; Markowitz J S; Rabkin J G; Tricamo E; Goetz D M; Klein D F
Antidepressant specificity in atypical depression.
Archives of general psychiatry 1988;45(2):129-37.
1988: Terman M; Terman J S; Quitkin F M; Cooper T B; Lo E S; Gorman J M; Stewart J W; McGrath P J
Response of the melatonin cycle to phototherapy for Seasonal Affective Disorder. Short note.
Journal of neural transmission 1988;72(2):147-65.
1988: Baron M; Barkai A; Kowalik S; Fieve R R; Quitkin F; Gruen R
Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects.
Neuropsychobiology 1988;19(1):9-11.
1987: McGrath P J; Blood D K; Stewart J W; Harrison W; Quitkin F M; Tricamo E; Markowitz J
A comparative study of the electrocardiographic effects of phenelzine, tricyclic antidepressants, mianserin, and placebo.
Journal of clinical psychopharmacology 1987;7(5):335-9.
1987: Nunes E; Quitkin F
Disulfiram and bipolar affective disorder.
Journal of clinical psychopharmacology 1987;7(4):284.
1987: Baron M; Barkai A; Gruen R; Peselow E; Fieve R R; Quitkin F
Platelet 3H-imipramine binding and familial transmission of affective disorders.
Neuropsychobiology 1987;17(4):182-6.
1987: Terman M; Quitkin F M; Terman J S; Stewart J W; McGrath P J
The timing of phototherapy: effects on clinical response and the melatonin cycle.
Psychopharmacology bulletin 1987;23(3):354-7.
1987: Markowitz J S; Rabkin J G; Stewart J; Tricamo E; McGrath P J; Harrison W; Ocepek-Welikson K; Quitkin F M
Validity assessment of SAFTEE: a preliminary report.
Psychopharmacology bulletin 1987;23(1):102-5.
1986: Rabkin J G; McGrath P; Stewart J W; Harrison W; Markowitz J S; Quitkin F
Follow-up of patients who improved during placebo washout.
Journal of clinical psychopharmacology 1986;6(5):274-8.
1986: Harrison W; Rabkin J; Stewart J W; McGrath P J; Tricamo E; Quitkin F
Phenelzine for chronic depression: a study of continuation treatment.
The Journal of clinical psychiatry 1986;47(7):346-9.
1986: Baron M; Barkai A; Gruen R; Peselow E; Fieve R R; Quitkin F
Platelet [3H]imipramine binding in affective disorders: trait versus state characteristics.
The American journal of psychiatry 1986;143(6):711-7.
1986: Harrison W M; Rabkin J G; Ehrhardt A A; Stewart J W; McGrath P J; Ross D; Quitkin F M
Effects of antidepressant medication on sexual function: a controlled study.
Journal of clinical psychopharmacology 1986;6(3):144-9.
1985: Rabkin J G; Quitkin F M; McGrath P; Harrison W; Tricamo E
Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.
Journal of clinical psychopharmacology 1985;5(1):2-9.
1985: Liebowitz M R; Quitkin F M; Stewart J W; McGrath P J; Harrison W; Rabkin J; Tricamo E; Markowitz J S; Klein D F
Effect of panic attacks on the treatment of atypical depressives.
Psychopharmacology bulletin 1985;21(3):558-61.
1985: Harrison W M; Stewart J; Ehrhardt A A; Rabkin J; McGrath P; Liebowitz M; Quitkin F M
A controlled study of the effects of antidepressants on sexual function.
Psychopharmacology bulletin 1985;21(1):85-8.
1984: Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P
Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
Journal of clinical psychopharmacology 1984;4(5):270-8.
1984: Harrison W M; Cooper T B; Stewart J W; Quitkin F M; McGrath P J; Liebowitz M R; Rabkin J R; Markowitz J S; Klein D F
The tyramine challenge test as a marker for melancholia.
Archives of general psychiatry 1984;41(7):681-5.
1984: Quitkin F M; Harrison W; Liebowitz M; McGrath P; Rabkin J G; Stewart J; Markowitz J
Defining the boundaries of atypical depression.
The Journal of clinical psychiatry 1984;45(7 Pt 2):19-21.
1984: Liebowitz M R; Quitkin F M; Stewart J W; McGrath P J; Harrison W; Rabkin J; Tricamo E; Markowitz J S; Klein D F
Phenelzine v imipramine in atypical depression. A preliminary report.
Archives of general psychiatry 1984;41(7):669-77.
1983: Baron M; Barkai A; Gruen R; Kowalik S; Quitkin F
3H-imipramine platelet binding sites in unipolar depression.
Biological psychiatry 1983;18(12):1403-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Frederic Quitkin

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Devices

Procedures

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Frederic Quitkin (preview)

All Publications